Advertisement

Effects of clomipramine hydrochloride on heart rate and rhythm in healthy dogs

View More View Less
  • 1 Department of Clinical Veterinary Medicine, University of Maisons-Alfort, 94704, Maisons-Alfort, France.
  • | 2 Department of Pharmacology, Centre de Recherches Biologiques, 18800, Baugy, France.
  • | 3 Department of Pharmacology, Centre de Recherches Biologiques, 18800, Baugy, France.
  • | 4 Department of Pharmacology, Centre de Recherches Biologiques, 18800, Baugy, France.
  • | 5 Novartis Animal Health Inc, Werk Rosental, CH-4002, Basel, Switzerland.

Abstract

Objective—To determine the effects of clomipramine hydrochloride on heart rate and rhythm in dogs.

Animals—17 healthy Beagles.

Procedures—In experiment 1, 8 dogs received placebo or clomipramine (20 mg/kg of body weight, q 24 h, PO) for 7 days in a 2-way crossover design. In experiment 2, 9 dogs were evaluated for 48 hours before and 24 hours after oral administration of clomipramine (4 or 12 mg/kg) in a 2-way crossover design. Electrocardiogram and heart rate were monitored continuously by use of telemetry.

Results—A significant diurnal rhythm in heart rate was detected; minimum values were recorded at night. Administration of 20 mg of clomipramine/kg induced a significant reduction in heart rate, with peak effect achieved approximately 12 hours after dosing. Administration of 4 or 12 mg of clomipramine/kg did not result in significant changes in heart rate. Sinoatrial and second-degree atrioventricular block and ventricular escape beats were observed during periods of slow heart rate in more dogs that received clomipramine (3 to 4 of 8 dogs), compared with dogs that received placebo (1 to 2 of 8 dogs), but this difference was not significant.

Conclusions and Clinical Relevance—Short-term administration of clomipramine induced benign cardiovascular effects in dogs rather than the potentially dangerous arrhythmias or tachycardia reported following administration of tricyclic antidepressants to humans. Precautions regarding cardiovascular effects may not be needed for the use of clomipramine in healthy dogs. (Am J Vet Res 2000;61:960–964)

Abstract

Objective—To determine the effects of clomipramine hydrochloride on heart rate and rhythm in dogs.

Animals—17 healthy Beagles.

Procedures—In experiment 1, 8 dogs received placebo or clomipramine (20 mg/kg of body weight, q 24 h, PO) for 7 days in a 2-way crossover design. In experiment 2, 9 dogs were evaluated for 48 hours before and 24 hours after oral administration of clomipramine (4 or 12 mg/kg) in a 2-way crossover design. Electrocardiogram and heart rate were monitored continuously by use of telemetry.

Results—A significant diurnal rhythm in heart rate was detected; minimum values were recorded at night. Administration of 20 mg of clomipramine/kg induced a significant reduction in heart rate, with peak effect achieved approximately 12 hours after dosing. Administration of 4 or 12 mg of clomipramine/kg did not result in significant changes in heart rate. Sinoatrial and second-degree atrioventricular block and ventricular escape beats were observed during periods of slow heart rate in more dogs that received clomipramine (3 to 4 of 8 dogs), compared with dogs that received placebo (1 to 2 of 8 dogs), but this difference was not significant.

Conclusions and Clinical Relevance—Short-term administration of clomipramine induced benign cardiovascular effects in dogs rather than the potentially dangerous arrhythmias or tachycardia reported following administration of tricyclic antidepressants to humans. Precautions regarding cardiovascular effects may not be needed for the use of clomipramine in healthy dogs. (Am J Vet Res 2000;61:960–964)